FDA advisory panel votes to keep COX-2s on market
Following three days of hearings last week, an FDA panel determined Friday that the COX-2 painkillers Vioxx, Celebrex and Bextra ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.